-
Venezuela earthquake deaths near 1,000, with millions more in need
-
Russell snatches controversial pole in Austria after Verstappen crash
-
French Open champs head to Wimbledon wrestling with new-found status
-
Davidovich Fokina wins in Mallorca for first ATP title
-
Budapest Pride marchers push for equality after reversed ban
-
Sabalenka urges Grand Slams to 'get it done' in prize money boycott row
-
Russell snatches pole, Antonelli fourth for Austria GP grid
-
Russell snatches pole as Verstappen, Antonelli fourth for Austria GP grid
-
Broos smiles and snarls before South Africa's historic World Cup match
-
Smith and supersub Foulkes strike for New Zealand in England finale
-
Newborn baby rescued from rubble of Venezuela quake
-
Supersub Foulkes strike for New Zealand in England finale
-
Raducanu halts practice session to put Wimbledon bid in doubt
-
Wolff says Russell will be at Mercedes next season
-
Keys beats Maria to clinch third Eastbourne title
-
Djokovic inspired by Serena as he targets history at Wimbledon
-
Thousands ride through Rome as Vespa celebrates 80 years
-
Stokes falls cheaply as England collapse in New Zealand decider
-
Sinner ready for Wimbledon defence despite lack of time on grass
-
Russell bounces back to beat Antonelli in final practice
-
Records tumble as European heatwave moves east
-
Iran says US violated peace deal as both sides trade fire
-
England, Portugal eye top spots as World Cup group stages wrap up
-
Injured Australian pair Leckie, Italiano out of World Cup
-
US, Iran trade strikes putting new strain on Middle East truce
-
Farmers fear drought as Italy's longest river runs dry
-
Thousands expected as Vespa celebrates 80 years in Rome
-
Budapest Pride to push for equality after reversed ban
-
Pino, Williams injuries mar Spain's World Cup progress
-
World Cup fans get taste of American life -- at the mall
-
'Struggle continues' in Bolivia's Morales heartland
-
World Cup turns New York's Times Square into global fan hub
-
Bielsa accepts blame for World Cup exit, but says Uruguay deserved more
-
Lebanon, Israel and US sign trilateral framework pact
-
Uruguay crash out of World Cup as Spain avoid Argentina clash
-
Cape Verde extend World Cup fairytale to set up Argentina meeting
-
Swiss glaciers facing drastic loss from heatwave: expert
-
Messi to start dead-rubber World Cup group match on bench
-
Trump unveils new US passport -- with picture of himself
-
Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
-
Epomaker Unveils the HE Lineup: Two Distinct Innovations Tailored to Community Demand
-
4 Budget-Friendly Ways to Update Your Living Room
-
US and Iran trade strikes putting new strain on Mideast ceasefire
-
Hat-trick hero Dembele displays Ballon d'Or brilliance for France at World Cup
-
Maple Leafs make teen McKenna top pick in NHL Draft
-
Injured England defender James to miss Panama game at World Cup
-
California appeals court orders Weinstein resentencing for sex assault
-
Norway coach defends decision to leave out Haaland, Odegaard against France
-
Scheffler fires 60 to grab 36-hole PGA Travelers lead
-
Movie theaters are allies for streamers like us, Apple exec says
First no-prescription birth control pill approved in US
US health authorities on Thursday approved the first over-the-counter birth control pill in the country, dramatically widening access to contraception for women in the United States where abortion rights are increasingly under assault.
The medication, Opill, will become available in pharmacies and supermarkets as well as online early next year, the manufacturer Perrigo said in a statement.
More than 100 countries already allow contraceptive pills to be sold over the counter. But in the United States approval comes after the Supreme Court last year scrapped federal abortion protections and the procedure is now banned in several states.
"Today's approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States," said Patrizia Cavazzoni, director of the Food and Drug Administration's Center for Drug Evaluation and Research in a statement.
"When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy."
The agency warned, however, that the pill should not be taken by women who have or have ever had breast cancer.
- 'Victory for equity' -
Almost half of the 6.1 million pregnancies in the United States each year are unintended, according to the FDA.
Allowing women to access the progestin-only daily contraceptive pill without needing to see a doctor first "may help reduce the number of unintended pregnancies and their potential negative impacts," the FDA statement said.
The pill, produced by the pharmaceutical company HRA Pharma, which was recently acquired by Perrigo, had already been authorized for prescription in the United States for a number of years.
"This moment is a victory for equity, human rights, public health, and evidence-based research—and especially in light of the ongoing attacks on reproductive health and rights, it is a reason to celebrate," said the Free the Pill coalition, a leading advocacy group.
Experts say the decision could be especially significant for teenage girls who may find it harder to get to the doctor, particularly if they want to do it on their own.
"An over-the-counter birth control pill has the potential to transform the way people access contraception, especially those who face the most barriers in our health care system, including LGBTQIA+ folks, people of color, and those working to make ends meet," said Lin-Fan Wang, a family physician serving the LGBTQ community and a Free the Pill member.
In May, an expert advisory committee convened by the FDA unanimously voted in favor of authorizing the sale of Perrigo without a prescription, judging that the benefits outweighed the risks.
The contraceptive pill, taken daily at the same time, prevents a pregnancy during sexual intercourse.
L.Adams--AT